BRAFキナーゼ阻害剤の世界市場 2024-2028Global BRAF Kinase Inhibitors Market 2024-2028 BRAFキナーゼ阻害剤の世界市場 2024-2028 BRAFキナーゼ阻害剤市場は2023〜2028年に14億米ドル成長し、予測期間中のCAGRは7.88%で加速すると予測される。当レポートでは、BRAFキナーゼ阻害剤市場の全体的な分析、... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーBRAFキナーゼ阻害剤の世界市場 2024-2028BRAFキナーゼ阻害剤市場は2023〜2028年に14億米ドル成長し、予測期間中のCAGRは7.88%で加速すると予測される。当レポートでは、BRAFキナーゼ阻害剤市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。 当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、BRAFキナーゼ阻害剤の高い標的親和性と特異性、患者支援プログラムの存在、癌の有病率の増加によって牽引されています。 TechnavioのBRAFキナーゼ阻害剤市場は以下のように区分される: 製品別 - ダブラフェニブ - ソラフェニブ - ベムラフェニブ - エンコラフェニブ 販売チャネル別 - 病院薬局 - 小売薬局 - オンライン薬局 地域別 - 北米 - ヨーロッパ - アジア - その他の地域(ROW) 本調査では、BRAFキナーゼ阻害剤の研究領域の拡大が、今後数年間のBRAFキナーゼ阻害剤市場の成長を促進する主要な理由の1つであるとしている。また、戦略的提携の拡大や癌に対する意識の高まりは、市場の大きな需要につながる。 本レポートでは、BRAFキナーゼ阻害剤市場について、以下の領域をカバーしている: - BRAFキナーゼ阻害剤市場のサイジング - BRAFキナーゼ阻害剤市場予測 - BRAFキナーゼ阻害剤市場の産業分析 本レポートでは、BRAFキナーゼ阻害剤市場の主要ベンダー(Asana BioSciences LLC、Bayer AG、BeiGene Ltd.、F. Hoffmann La Roche Ltd.、Fore Biotherapeutics Inc.、Jazz Pharmaceuticals Plc、Nerviano Medical Sciences S.r.l.、Novartis AG、Ono Pharmaceutical Co.Ltd.、ファイザーInc.、Pierre Fabre SA、Kinnate Biopharma、Black Diamond Therapeutics Inc.また、BRAFキナーゼ阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。 本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/braf-kinase-inhibitors-market-industry-analysis をご覧ください。 当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。 目次• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2023 o 3.4 Market outlook: Forecast for 2023-2028 o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) • 4 Historic Market Size o 4.1 Global BRAF kinase inhibitors market 2018 - 2022 o Exhibit 18: Historic Market Size - Data Table on global braf kinase inhibitors market 2018 - 2022 ($ billion) o 4.2 Product Segment Analysis 2018 - 2022 o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion) o 4.3 Type Segment Analysis 2018 - 2022 o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) o 4.4 Geography Segment Analysis 2018 - 2022 o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) o 4.5 Country Segment Analysis 2018 - 2022 o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2023-2028 (%) o Exhibit 31: Data Table on Product - Market share 2023-2028 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Dabrafenib - Market size and forecast 2023-2028 o Exhibit 34: Chart on Dabrafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 35: Data Table on Dabrafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 36: Chart on Dabrafenib - Year-over-year growth 2023-2028 (%) o Exhibit 37: Data Table on Dabrafenib - Year-over-year growth 2023-2028 (%) o 6.4 Sorafenib - Market size and forecast 2023-2028 o Exhibit 38: Chart on Sorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 39: Data Table on Sorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 40: Chart on Sorafenib - Year-over-year growth 2023-2028 (%) o Exhibit 41: Data Table on Sorafenib - Year-over-year growth 2023-2028 (%) o 6.5 Vemurafenib - Market size and forecast 2023-2028 o Exhibit 42: Chart on Vemurafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 43: Data Table on Vemurafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 44: Chart on Vemurafenib - Year-over-year growth 2023-2028 (%) o Exhibit 45: Data Table on Vemurafenib - Year-over-year growth 2023-2028 (%) o 6.6 Encorafenib - Market size and forecast 2023-2028 o Exhibit 46: Chart on Encorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 47: Data Table on Encorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 48: Chart on Encorafenib - Year-over-year growth 2023-2028 (%) o Exhibit 49: Data Table on Encorafenib - Year-over-year growth 2023-2028 (%) o 6.7 Market opportunity by Product o Exhibit 50: Market opportunity by Product ($ billion) o Exhibit 51: Data Table on Market opportunity by Product ($ billion) • 7 Market Segmentation by Distribution Channel o 7.1 Market segments o Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%) o Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%) o 7.2 Comparison by Distribution Channel o Exhibit 54: Chart on Comparison by Distribution Channel o Exhibit 55: Data Table on Comparison by Distribution Channel o 7.3 Hospital pharmacies - Market size and forecast 2023-2028 o Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%) o 7.4 Retail pharmacies - Market size and forecast 2023-2028 o Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%) o 7.5 Online pharmacies - Market size and forecast 2023-2028 o Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%) o 7.6 Market opportunity by Distribution Channel o Exhibit 68: Market opportunity by Distribution Channel ($ billion) o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%) o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%) o 9.2 Geographic comparison o Exhibit 73: Chart on Geographic comparison o Exhibit 74: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2023-2028 o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%) o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%) o 9.4 Europe - Market size and forecast 2023-2028 o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%) o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%) o 9.5 Asia - Market size and forecast 2023-2028 o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%) o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028 o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o 9.7 US - Market size and forecast 2023-2028 o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%) o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%) o 9.8 Germany - Market size and forecast 2023-2028 o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%) o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%) o 9.9 UK - Market size and forecast 2023-2028 o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%) o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%) o 9.10 France - Market size and forecast 2023-2028 o Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%) o Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%) o 9.11 Japan - Market size and forecast 2023-2028 o Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%) o Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 111: Market opportunity By Geographical Landscape ($ billion) o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 113: Impact of drivers and challenges in 2023 and 2028 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 115: Overview on factors of disruption o 11.4 Industry risks o Exhibit 116: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 117: Vendors covered o 12.2 Market positioning of vendors o Exhibit 118: Matrix on vendor position and classification o 12.3 Asana BioSciences LLC o Exhibit 119: Asana BioSciences LLC - Overview o Exhibit 120: Asana BioSciences LLC - Product / Service o Exhibit 121: Asana BioSciences LLC - Key offerings o 12.4 Bayer AG o Exhibit 122: Bayer AG - Overview o Exhibit 123: Bayer AG - Business segments o Exhibit 124: Bayer AG - Key news o Exhibit 125: Bayer AG - Key offerings o Exhibit 126: Bayer AG - Segment focus o 12.5 BeiGene Ltd. o Exhibit 127: BeiGene Ltd. - Overview o Exhibit 128: BeiGene Ltd. - Business segments o Exhibit 129: BeiGene Ltd. - Key offerings o Exhibit 130: BeiGene Ltd. - Segment focus o 12.6 Black Diamond Therapeutics Inc. o Exhibit 131: Black Diamond Therapeutics Inc. - Overview o Exhibit 132: Black Diamond Therapeutics Inc. - Product / Service o Exhibit 133: Black Diamond Therapeutics Inc. - Key offerings o 12.7 F. Hoffmann La Roche Ltd. o Exhibit 134: F. Hoffmann La Roche Ltd. - Overview o Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 136: F. Hoffmann La Roche Ltd. - Key news o Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus o 12.8 Fore Biotherapeutics Inc. o Exhibit 139: Fore Biotherapeutics Inc. - Overview o Exhibit 140: Fore Biotherapeutics Inc. - Product / Service o Exhibit 141: Fore Biotherapeutics Inc. - Key offerings o 12.9 Jazz Pharmaceuticals Plc o Exhibit 142: Jazz Pharmaceuticals Plc - Overview o Exhibit 143: Jazz Pharmaceuticals Plc - Product / Service o Exhibit 144: Jazz Pharmaceuticals Plc - Key news o Exhibit 145: Jazz Pharmaceuticals Plc - Key offerings o 12.10 Kinnate Biopharma o Exhibit 146: Kinnate Biopharma - Overview o Exhibit 147: Kinnate Biopharma - Product / Service o Exhibit 148: Kinnate Biopharma - Key offerings o 12.11 Nerviano Medical Sciences S.r.l o Exhibit 149: Nerviano Medical Sciences S.r.l - Overview o Exhibit 150: Nerviano Medical Sciences S.r.l - Product / Service o Exhibit 151: Nerviano Medical Sciences S.r.l - Key offerings o 12.12 Novartis AG o Exhibit 152: Novartis AG - Overview o Exhibit 153: Novartis AG - Business segments o Exhibit 154: Novartis AG - Key offerings o Exhibit 155: Novartis AG - Segment focus o 12.13 Ono Pharmaceutical Co. Ltd. o Exhibit 156: Ono Pharmaceutical Co. Ltd. - Overview o Exhibit 157: Ono Pharmaceutical Co. Ltd. - Product / Service o Exhibit 158: Ono Pharmaceutical Co. Ltd. - Key offerings o 12.14 Pfizer Inc. o Exhibit 159: Pfizer Inc. - Overview o Exhibit 160: Pfizer Inc. - Product / Service o Exhibit 161: Pfizer Inc. - Key news o Exhibit 162: Pfizer Inc. - Key offerings o 12.15 Pierre Fabre SA o Exhibit 163: Pierre Fabre SA - Overview o Exhibit 164: Pierre Fabre SA - Business segments o Exhibit 165: Pierre Fabre SA - Key offerings o Exhibit 166: Pierre Fabre SA - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 167: Inclusions checklist o Exhibit 168: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 169: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 170: Research methodology o Exhibit 171: Validation techniques employed for market sizing o Exhibit 172: Information sources o 13.5 List of abbreviations o Exhibit 173: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) Exhibits18: Historic Market Size - Data Table on global braf kinase inhibitors market 2018 - 2022 ($ billion) Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion) Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) Exhibits23: Five forces analysis - Comparison between 2023 and 2028 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028 Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028 Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028 Exhibits29: Chart on Market condition - Five forces 2023 and 2028 Exhibits30: Chart on Product - Market share 2023-2028 (%) Exhibits31: Data Table on Product - Market share 2023-2028 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Dabrafenib - Market size and forecast 2023-2028 ($ billion) Exhibits35: Data Table on Dabrafenib - Market size and forecast 2023-2028 ($ billion) Exhibits36: Chart on Dabrafenib - Year-over-year growth 2023-2028 (%) Exhibits37: Data Table on Dabrafenib - Year-over-year growth 2023-2028 (%) Exhibits38: Chart on Sorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits39: Data Table on Sorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits40: Chart on Sorafenib - Year-over-year growth 2023-2028 (%) Exhibits41: Data Table on Sorafenib - Year-over-year growth 2023-2028 (%) Exhibits42: Chart on Vemurafenib - Market size and forecast 2023-2028 ($ billion) Exhibits43: Data Table on Vemurafenib - Market size and forecast 2023-2028 ($ billion) Exhibits44: Chart on Vemurafenib - Year-over-year growth 2023-2028 (%) Exhibits45: Data Table on Vemurafenib - Year-over-year growth 2023-2028 (%) Exhibits46: Chart on Encorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits47: Data Table on Encorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits48: Chart on Encorafenib - Year-over-year growth 2023-2028 (%) Exhibits49: Data Table on Encorafenib - Year-over-year growth 2023-2028 (%) Exhibits50: Market opportunity by Product ($ billion) Exhibits51: Data Table on Market opportunity by Product ($ billion) Exhibits52: Chart on Distribution Channel - Market share 2023-2028 (%) Exhibits53: Data Table on Distribution Channel - Market share 2023-2028 (%) Exhibits54: Chart on Comparison by Distribution Channel Exhibits55: Data Table on Comparison by Distribution Channel Exhibits56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%) Exhibits59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%) Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%) Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%) Exhibits64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%) Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%) Exhibits68: Market opportunity by Distribution Channel ($ billion) Exhibits69: Data Table on Market opportunity by Distribution Channel ($ billion) Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%) Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%) Exhibits73: Chart on Geographic comparison Exhibits74: Data Table on Geographic comparison Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion) Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%) Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%) Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%) Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%) Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%) Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%) Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion) Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion) Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%) Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%) Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%) Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%) Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion) Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion) Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%) Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%) Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion) Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion) Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%) Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%) Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%) Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%) Exhibits111: Market opportunity By Geographical Landscape ($ billion) Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion) Exhibits113: Impact of drivers and challenges in 2023 and 2028 Exhibits114: Overview on Criticality of inputs and Factors of differentiation Exhibits115: Overview on factors of disruption Exhibits116: Impact of key risks on business Exhibits117: Vendors covered Exhibits118: Matrix on vendor position and classification Exhibits119: Asana BioSciences LLC - Overview Exhibits120: Asana BioSciences LLC - Product / Service Exhibits121: Asana BioSciences LLC - Key offerings Exhibits122: Bayer AG - Overview Exhibits123: Bayer AG - Business segments Exhibits124: Bayer AG - Key news Exhibits125: Bayer AG - Key offerings Exhibits126: Bayer AG - Segment focus Exhibits127: BeiGene Ltd. - Overview Exhibits128: BeiGene Ltd. - Business segments Exhibits129: BeiGene Ltd. - Key offerings Exhibits130: BeiGene Ltd. - Segment focus Exhibits131: Black Diamond Therapeutics Inc. - Overview Exhibits132: Black Diamond Therapeutics Inc. - Product / Service Exhibits133: Black Diamond Therapeutics Inc. - Key offerings Exhibits134: F. Hoffmann La Roche Ltd. - Overview Exhibits135: F. Hoffmann La Roche Ltd. - Business segments Exhibits136: F. Hoffmann La Roche Ltd. - Key news Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus Exhibits139: Fore Biotherapeutics Inc. - Overview Exhibits140: Fore Biotherapeutics Inc. - Product / Service Exhibits141: Fore Biotherapeutics Inc. - Key offerings Exhibits142: Jazz Pharmaceuticals Plc - Overview Exhibits143: Jazz Pharmaceuticals Plc - Product / Service Exhibits144: Jazz Pharmaceuticals Plc - Key news Exhibits145: Jazz Pharmaceuticals Plc - Key offerings Exhibits146: Kinnate Biopharma - Overview Exhibits147: Kinnate Biopharma - Product / Service Exhibits148: Kinnate Biopharma - Key offerings Exhibits149: Nerviano Medical Sciences S.r.l - Overview Exhibits150: Nerviano Medical Sciences S.r.l - Product / Service Exhibits151: Nerviano Medical Sciences S.r.l - Key offerings Exhibits152: Novartis AG - Overview Exhibits153: Novartis AG - Business segments Exhibits154: Novartis AG - Key offerings Exhibits155: Novartis AG - Segment focus Exhibits156: Ono Pharmaceutical Co. Ltd. - Overview Exhibits157: Ono Pharmaceutical Co. Ltd. - Product / Service Exhibits158: Ono Pharmaceutical Co. Ltd. - Key offerings Exhibits159: Pfizer Inc. - Overview Exhibits160: Pfizer Inc. - Product / Service Exhibits161: Pfizer Inc. - Key news Exhibits162: Pfizer Inc. - Key offerings Exhibits163: Pierre Fabre SA - Overview Exhibits164: Pierre Fabre SA - Business segments Exhibits165: Pierre Fabre SA - Key offerings Exhibits166: Pierre Fabre SA - Segment focus Exhibits167: Inclusions checklist Exhibits168: Exclusions checklist Exhibits169: Currency conversion rates for US$ Exhibits170: Research methodology Exhibits171: Validation techniques employed for market sizing Exhibits172: Information sources Exhibits173: List of abbreviations
SummaryGlobal BRAF Kinase Inhibitors Market 2024-2028 Table of Contents• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2023 o 3.4 Market outlook: Forecast for 2023-2028 o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) • 4 Historic Market Size o 4.1 Global BRAF kinase inhibitors market 2018 - 2022 o Exhibit 18: Historic Market Size - Data Table on global braf kinase inhibitors market 2018 - 2022 ($ billion) o 4.2 Product Segment Analysis 2018 - 2022 o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion) o 4.3 Type Segment Analysis 2018 - 2022 o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) o 4.4 Geography Segment Analysis 2018 - 2022 o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) o 4.5 Country Segment Analysis 2018 - 2022 o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2023-2028 (%) o Exhibit 31: Data Table on Product - Market share 2023-2028 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Dabrafenib - Market size and forecast 2023-2028 o Exhibit 34: Chart on Dabrafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 35: Data Table on Dabrafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 36: Chart on Dabrafenib - Year-over-year growth 2023-2028 (%) o Exhibit 37: Data Table on Dabrafenib - Year-over-year growth 2023-2028 (%) o 6.4 Sorafenib - Market size and forecast 2023-2028 o Exhibit 38: Chart on Sorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 39: Data Table on Sorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 40: Chart on Sorafenib - Year-over-year growth 2023-2028 (%) o Exhibit 41: Data Table on Sorafenib - Year-over-year growth 2023-2028 (%) o 6.5 Vemurafenib - Market size and forecast 2023-2028 o Exhibit 42: Chart on Vemurafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 43: Data Table on Vemurafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 44: Chart on Vemurafenib - Year-over-year growth 2023-2028 (%) o Exhibit 45: Data Table on Vemurafenib - Year-over-year growth 2023-2028 (%) o 6.6 Encorafenib - Market size and forecast 2023-2028 o Exhibit 46: Chart on Encorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 47: Data Table on Encorafenib - Market size and forecast 2023-2028 ($ billion) o Exhibit 48: Chart on Encorafenib - Year-over-year growth 2023-2028 (%) o Exhibit 49: Data Table on Encorafenib - Year-over-year growth 2023-2028 (%) o 6.7 Market opportunity by Product o Exhibit 50: Market opportunity by Product ($ billion) o Exhibit 51: Data Table on Market opportunity by Product ($ billion) • 7 Market Segmentation by Distribution Channel o 7.1 Market segments o Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%) o Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%) o 7.2 Comparison by Distribution Channel o Exhibit 54: Chart on Comparison by Distribution Channel o Exhibit 55: Data Table on Comparison by Distribution Channel o 7.3 Hospital pharmacies - Market size and forecast 2023-2028 o Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%) o 7.4 Retail pharmacies - Market size and forecast 2023-2028 o Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%) o 7.5 Online pharmacies - Market size and forecast 2023-2028 o Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion) o Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%) o Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%) o 7.6 Market opportunity by Distribution Channel o Exhibit 68: Market opportunity by Distribution Channel ($ billion) o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%) o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%) o 9.2 Geographic comparison o Exhibit 73: Chart on Geographic comparison o Exhibit 74: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2023-2028 o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%) o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%) o 9.4 Europe - Market size and forecast 2023-2028 o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%) o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%) o 9.5 Asia - Market size and forecast 2023-2028 o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%) o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028 o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o 9.7 US - Market size and forecast 2023-2028 o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%) o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%) o 9.8 Germany - Market size and forecast 2023-2028 o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%) o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%) o 9.9 UK - Market size and forecast 2023-2028 o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%) o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%) o 9.10 France - Market size and forecast 2023-2028 o Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%) o Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%) o 9.11 Japan - Market size and forecast 2023-2028 o Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%) o Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 111: Market opportunity By Geographical Landscape ($ billion) o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 113: Impact of drivers and challenges in 2023 and 2028 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 115: Overview on factors of disruption o 11.4 Industry risks o Exhibit 116: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 117: Vendors covered o 12.2 Market positioning of vendors o Exhibit 118: Matrix on vendor position and classification o 12.3 Asana BioSciences LLC o Exhibit 119: Asana BioSciences LLC - Overview o Exhibit 120: Asana BioSciences LLC - Product / Service o Exhibit 121: Asana BioSciences LLC - Key offerings o 12.4 Bayer AG o Exhibit 122: Bayer AG - Overview o Exhibit 123: Bayer AG - Business segments o Exhibit 124: Bayer AG - Key news o Exhibit 125: Bayer AG - Key offerings o Exhibit 126: Bayer AG - Segment focus o 12.5 BeiGene Ltd. o Exhibit 127: BeiGene Ltd. - Overview o Exhibit 128: BeiGene Ltd. - Business segments o Exhibit 129: BeiGene Ltd. - Key offerings o Exhibit 130: BeiGene Ltd. - Segment focus o 12.6 Black Diamond Therapeutics Inc. o Exhibit 131: Black Diamond Therapeutics Inc. - Overview o Exhibit 132: Black Diamond Therapeutics Inc. - Product / Service o Exhibit 133: Black Diamond Therapeutics Inc. - Key offerings o 12.7 F. Hoffmann La Roche Ltd. o Exhibit 134: F. Hoffmann La Roche Ltd. - Overview o Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 136: F. Hoffmann La Roche Ltd. - Key news o Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus o 12.8 Fore Biotherapeutics Inc. o Exhibit 139: Fore Biotherapeutics Inc. - Overview o Exhibit 140: Fore Biotherapeutics Inc. - Product / Service o Exhibit 141: Fore Biotherapeutics Inc. - Key offerings o 12.9 Jazz Pharmaceuticals Plc o Exhibit 142: Jazz Pharmaceuticals Plc - Overview o Exhibit 143: Jazz Pharmaceuticals Plc - Product / Service o Exhibit 144: Jazz Pharmaceuticals Plc - Key news o Exhibit 145: Jazz Pharmaceuticals Plc - Key offerings o 12.10 Kinnate Biopharma o Exhibit 146: Kinnate Biopharma - Overview o Exhibit 147: Kinnate Biopharma - Product / Service o Exhibit 148: Kinnate Biopharma - Key offerings o 12.11 Nerviano Medical Sciences S.r.l o Exhibit 149: Nerviano Medical Sciences S.r.l - Overview o Exhibit 150: Nerviano Medical Sciences S.r.l - Product / Service o Exhibit 151: Nerviano Medical Sciences S.r.l - Key offerings o 12.12 Novartis AG o Exhibit 152: Novartis AG - Overview o Exhibit 153: Novartis AG - Business segments o Exhibit 154: Novartis AG - Key offerings o Exhibit 155: Novartis AG - Segment focus o 12.13 Ono Pharmaceutical Co. Ltd. o Exhibit 156: Ono Pharmaceutical Co. Ltd. - Overview o Exhibit 157: Ono Pharmaceutical Co. Ltd. - Product / Service o Exhibit 158: Ono Pharmaceutical Co. Ltd. - Key offerings o 12.14 Pfizer Inc. o Exhibit 159: Pfizer Inc. - Overview o Exhibit 160: Pfizer Inc. - Product / Service o Exhibit 161: Pfizer Inc. - Key news o Exhibit 162: Pfizer Inc. - Key offerings o 12.15 Pierre Fabre SA o Exhibit 163: Pierre Fabre SA - Overview o Exhibit 164: Pierre Fabre SA - Business segments o Exhibit 165: Pierre Fabre SA - Key offerings o Exhibit 166: Pierre Fabre SA - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 167: Inclusions checklist o Exhibit 168: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 169: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 170: Research methodology o Exhibit 171: Validation techniques employed for market sizing o Exhibit 172: Information sources o 13.5 List of abbreviations o Exhibit 173: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) Exhibits18: Historic Market Size - Data Table on global braf kinase inhibitors market 2018 - 2022 ($ billion) Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion) Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) Exhibits23: Five forces analysis - Comparison between 2023 and 2028 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028 Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028 Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028 Exhibits29: Chart on Market condition - Five forces 2023 and 2028 Exhibits30: Chart on Product - Market share 2023-2028 (%) Exhibits31: Data Table on Product - Market share 2023-2028 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Dabrafenib - Market size and forecast 2023-2028 ($ billion) Exhibits35: Data Table on Dabrafenib - Market size and forecast 2023-2028 ($ billion) Exhibits36: Chart on Dabrafenib - Year-over-year growth 2023-2028 (%) Exhibits37: Data Table on Dabrafenib - Year-over-year growth 2023-2028 (%) Exhibits38: Chart on Sorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits39: Data Table on Sorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits40: Chart on Sorafenib - Year-over-year growth 2023-2028 (%) Exhibits41: Data Table on Sorafenib - Year-over-year growth 2023-2028 (%) Exhibits42: Chart on Vemurafenib - Market size and forecast 2023-2028 ($ billion) Exhibits43: Data Table on Vemurafenib - Market size and forecast 2023-2028 ($ billion) Exhibits44: Chart on Vemurafenib - Year-over-year growth 2023-2028 (%) Exhibits45: Data Table on Vemurafenib - Year-over-year growth 2023-2028 (%) Exhibits46: Chart on Encorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits47: Data Table on Encorafenib - Market size and forecast 2023-2028 ($ billion) Exhibits48: Chart on Encorafenib - Year-over-year growth 2023-2028 (%) Exhibits49: Data Table on Encorafenib - Year-over-year growth 2023-2028 (%) Exhibits50: Market opportunity by Product ($ billion) Exhibits51: Data Table on Market opportunity by Product ($ billion) Exhibits52: Chart on Distribution Channel - Market share 2023-2028 (%) Exhibits53: Data Table on Distribution Channel - Market share 2023-2028 (%) Exhibits54: Chart on Comparison by Distribution Channel Exhibits55: Data Table on Comparison by Distribution Channel Exhibits56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%) Exhibits59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%) Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%) Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%) Exhibits64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion) Exhibits66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%) Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%) Exhibits68: Market opportunity by Distribution Channel ($ billion) Exhibits69: Data Table on Market opportunity by Distribution Channel ($ billion) Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%) Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%) Exhibits73: Chart on Geographic comparison Exhibits74: Data Table on Geographic comparison Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion) Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%) Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%) Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%) Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%) Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%) Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%) Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion) Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion) Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%) Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%) Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%) Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%) Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion) Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion) Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%) Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%) Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion) Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion) Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%) Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%) Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%) Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%) Exhibits111: Market opportunity By Geographical Landscape ($ billion) Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion) Exhibits113: Impact of drivers and challenges in 2023 and 2028 Exhibits114: Overview on Criticality of inputs and Factors of differentiation Exhibits115: Overview on factors of disruption Exhibits116: Impact of key risks on business Exhibits117: Vendors covered Exhibits118: Matrix on vendor position and classification Exhibits119: Asana BioSciences LLC - Overview Exhibits120: Asana BioSciences LLC - Product / Service Exhibits121: Asana BioSciences LLC - Key offerings Exhibits122: Bayer AG - Overview Exhibits123: Bayer AG - Business segments Exhibits124: Bayer AG - Key news Exhibits125: Bayer AG - Key offerings Exhibits126: Bayer AG - Segment focus Exhibits127: BeiGene Ltd. - Overview Exhibits128: BeiGene Ltd. - Business segments Exhibits129: BeiGene Ltd. - Key offerings Exhibits130: BeiGene Ltd. - Segment focus Exhibits131: Black Diamond Therapeutics Inc. - Overview Exhibits132: Black Diamond Therapeutics Inc. - Product / Service Exhibits133: Black Diamond Therapeutics Inc. - Key offerings Exhibits134: F. Hoffmann La Roche Ltd. - Overview Exhibits135: F. Hoffmann La Roche Ltd. - Business segments Exhibits136: F. Hoffmann La Roche Ltd. - Key news Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus Exhibits139: Fore Biotherapeutics Inc. - Overview Exhibits140: Fore Biotherapeutics Inc. - Product / Service Exhibits141: Fore Biotherapeutics Inc. - Key offerings Exhibits142: Jazz Pharmaceuticals Plc - Overview Exhibits143: Jazz Pharmaceuticals Plc - Product / Service Exhibits144: Jazz Pharmaceuticals Plc - Key news Exhibits145: Jazz Pharmaceuticals Plc - Key offerings Exhibits146: Kinnate Biopharma - Overview Exhibits147: Kinnate Biopharma - Product / Service Exhibits148: Kinnate Biopharma - Key offerings Exhibits149: Nerviano Medical Sciences S.r.l - Overview Exhibits150: Nerviano Medical Sciences S.r.l - Product / Service Exhibits151: Nerviano Medical Sciences S.r.l - Key offerings Exhibits152: Novartis AG - Overview Exhibits153: Novartis AG - Business segments Exhibits154: Novartis AG - Key offerings Exhibits155: Novartis AG - Segment focus Exhibits156: Ono Pharmaceutical Co. Ltd. - Overview Exhibits157: Ono Pharmaceutical Co. Ltd. - Product / Service Exhibits158: Ono Pharmaceutical Co. Ltd. - Key offerings Exhibits159: Pfizer Inc. - Overview Exhibits160: Pfizer Inc. - Product / Service Exhibits161: Pfizer Inc. - Key news Exhibits162: Pfizer Inc. - Key offerings Exhibits163: Pierre Fabre SA - Overview Exhibits164: Pierre Fabre SA - Business segments Exhibits165: Pierre Fabre SA - Key offerings Exhibits166: Pierre Fabre SA - Segment focus Exhibits167: Inclusions checklist Exhibits168: Exclusions checklist Exhibits169: Currency conversion rates for US$ Exhibits170: Research methodology Exhibits171: Validation techniques employed for market sizing Exhibits172: Information sources Exhibits173: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポートTechNavio社のHealth Care分野での最新刊レポート本レポートと同じKEY WORD(inhibitors)の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |